PharVision Advisers’s Graco GGG Stock Holding History

PharVision Advisers’s Portfolio GGG Stock Details GGG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-2,538	Closed	-$218K	–	712
2025 Q2	$218K	Buy	+2,538	New	+$210K	0.31%	176

Other funds holding GGG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return

MPI

Mairs & Power Inc St Paul, Minnesota $9.79B AUM 20.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PAM

PineStone Asset Management Montreal, Quebec, Canada $16.2B AUM 25.74% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return

PharVision Advisers's GGG Position: Q3 2025 in Review

PharVision Advisers sold out of Graco (GGG) in Q3 2025, closing a stake of 2,538 shares — an estimated $218K sold.

PharVision Advisers first reported a position in GGG in Q2 2025 and held it in 1 quarter. The position peaked at $218K in Q2 2025. 707 funds tracked by Wall St. Rank hold GGG as of Q3 2025.

PharVision Advisers reported no remaining Graco position as of Q3 2025 after selling out during the quarter.
PharVision Advisers sold 2,538 Graco shares in Q3 2025, an estimated $218K.
PharVision Advisers first reported a position in Graco in Q2 2025 and held it in 1 quarter.
PharVision Advisers's Graco position peaked at $218K in Q2 2025.
707 funds tracked by Wall St. Rank held Graco as of Q3 2025.

Based on PharVision Advisers's 13F filing for Q3 2025, filed 17 Nov 2025.